3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
109
Recruiting
29
Completed
28
Not yet recruiting
20
Active not recruiting
9
Withdrawn
4
Terminated
4
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Interventions
Gemcitabine
7
Specimen Handling
6
Oxaliplatin
5
Irinotecan
5
S 1 (combination)
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
Capecitabine
4
Biopsy
4
Bevacizumab
4
Radiotherapy
3
Nivolumab
3
Immunotherapy
3
Drug Therapy
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
trifluridine tipiracil drug combination
2
titanium silicide
2
spartalizumab
2
lenvatinib
2
aldesleukin
2
Taxes
2
Surgical Procedures, Operative
2
Radiosurgery
2
Photochemotherapy
2
Interleukin-2
2
Endoscopic Mucosal Resection
2
Cyclophosphamide
2
Cisplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
apatinib
×
Gastrointestinal
×
Clear all
NCT03743428
2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA
Suspended
40 enrolled